Biofabrication of a Novel Biomolecule-assisted Reduced Graphene Oxide: an Excellent Biocompatible Nanomaterial

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2016 Dec 21

PMID 27994461

Citations 10

Authors

Xi-Feng Zhang

Sangiliyandi Gurunathan

Affiliations

Soon will be listed here.

Abstract

Graphene has been shown much interest, both in academics and industry due to its extraordinary physical, chemical, and biological proprieties. It shows great promises in biotechnological and biomedical applications as an antibacterial and anticancer agent, nanocarrier, sensor, etc. However, many studies demonstrated the toxicity of graphene in several cell lines, which is an obstacle to its use in biomedical applications. In this study, to improve the biocompatibility of graphene, we used nicotinamide (NAM) as a reducing and stabilizing agent to catalyze the reduction of graphene oxide (GO) to reduced graphene oxide (rGO). The resulted smaller-sized GO (NAM-rGO) showed excellent biocompatibility with mouse embryonic fibroblast cells, evidenced by various cellular assays. Furthermore, NAM-rGO had no effect on mitochondrial membrane permeability and caspase-3 activity compared to GO. Reverse transcription polymerase chain reaction analysis allowed us to identify the molecular mechanisms responsible for NAM-rGO-induced biocompatibility. NAM-rGO significantly induced the expression of genes encoding tight junction proteins (TJPs) such as zona occludens-1 () and claudins () without any effect on the expression of cytoskeleton proteins. Furthermore, NAM-rGO enhances the expression of alkaline phosphatase () gene, and it does this in a time-dependent manner. Overall, our study depicted the molecular mechanisms underlying NAM-rGO biocompatibility depending on upregulation of TJPs and ALP. This potential quality of graphene could be used in diverse applications including tissue regeneration and tissue engineering.

Citing Articles

In Vitro Assessment of the Genotoxic Potential of Pristine Graphene Platelets.

Malkova A, Svadlakova T, Singh A, Kolackova M, Vankova R, Borsky P Nanomaterials (Basel). 2021; 11(9).

PMID: 34578525 PMC: 8470272. DOI: 10.3390/nano11092210.

Nanocomposite Cellulose Fibres Doped with Graphene Oxide and Their Biocidal Properties.

Gabrys T, Fryczkowska B, Machnicka A, Graczyk T Polymers (Basel). 2021; 13(2).

PMID: 33430074 PMC: 7827094. DOI: 10.3390/polym13020204.

Reduced Graphene Oxide Nanosheet-Decorated Copper Oxide Nanoparticles: A Potent Antifungal Nanocomposite against Fusarium Root Rot and Wilt Diseases of Tomato and Pepper Plants.

El-Abeid S, Ahmed Y, Daros J, Mohamed M Nanomaterials (Basel). 2020; 10(5).

PMID: 32456282 PMC: 7281300. DOI: 10.3390/nano10051001.

Differential Immunomodulatory Effect of Graphene Oxide and Vanillin-Functionalized Graphene Oxide Nanoparticles in Human Acute Monocytic Leukemia Cell Line (THP-1).

Gurunathan S, Kang M, Jeyaraj M, Kim J Int J Mol Sci. 2019; 20(2).

PMID: 30634552 PMC: 6359521. DOI: 10.3390/ijms20020247.

Theranostics Aspects of Various Nanoparticles in Veterinary Medicine.

Bai D, Lin X, Huang Y, Zhang X Int J Mol Sci. 2018; 19(11).

PMID: 30352960 PMC: 6274759. DOI: 10.3390/ijms19113299.

References

Ferrari A, Meyer J, Scardaci V, Casiraghi C, Lazzeri M, Mauri F . Raman spectrum of graphene and graphene layers. Phys Rev Lett. 2006; 97(18):187401. DOI: 10.1103/PhysRevLett.97.187401. View

Li Y, Liu Y, Fu Y, Wei T, Le Guyader L, Gao G . The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways. Biomaterials. 2011; 33(2):402-11. DOI: 10.1016/j.biomaterials.2011.09.091. View

Bunnell T, Ervasti J . Delayed embryonic development and impaired cell growth and survival in Actg1 null mice. Cytoskeleton (Hoboken). 2010; 67(9):564-72. PMC: 2989386. DOI: 10.1002/cm.20467. View

Gogvadze V, Orrenius S . Mitochondrial regulation of apoptotic cell death. Chem Biol Interact. 2006; 163(1-2):4-14. DOI: 10.1016/j.cbi.2006.04.010. View

Gurunathan S, Han J, Park J, Eppakayala V, Kim J . Ginkgo biloba: a natural reducing agent for the synthesis of cytocompatible graphene. Int J Nanomedicine. 2014; 9:363-77. PMC: 3890967. DOI: 10.2147/IJN.S53538. View

Zhang Y, Ali S, Dervishi E, Xu Y, Li Z, Casciano D . Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano. 2010; 4(6):3181-6. DOI: 10.1021/nn1007176. View

Akhavan O, Ghaderi E . Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano. 2010; 4(10):5731-6. DOI: 10.1021/nn101390x. View

Gottlieb R . Mitochondrial signaling in apoptosis: mitochondrial daggers to the breaking heart. Basic Res Cardiol. 2003; 98(4):242-9. DOI: 10.1007/s00395-003-0404-0. View

Singh S, Singh M, Kulkarni P, Sonkar V, Gracio J, Dash D . Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications. ACS Nano. 2012; 6(3):2731-40. DOI: 10.1021/nn300172t. View

10.

Duch M, Budinger G, Liang Y, Soberanes S, Urich D, Chiarella S . Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. Nano Lett. 2011; 11(12):5201-7. PMC: 3237757. DOI: 10.1021/nl202515a. View

11.

Guo H, Wang X, Qian Q, Wang F, Xia X . A green approach to the synthesis of graphene nanosheets. ACS Nano. 2009; 3(9):2653-9. DOI: 10.1021/nn900227d. View

12.

Wang Y, Shi Z, Yin J . Facile synthesis of soluble graphene via a green reduction of graphene oxide in tea solution and its biocomposites. ACS Appl Mater Interfaces. 2011; 3(4):1127-33. DOI: 10.1021/am1012613. View

13.

Chung C, Kim Y, Shin D, Ryoo S, Hong B, Min D . Biomedical applications of graphene and graphene oxide. Acc Chem Res. 2013; 46(10):2211-24. DOI: 10.1021/ar300159f. View

14.

Xu M, Zhu J, Wang F, Xiong Y, Wu Y, Wang Q . Improved In Vitro and In Vivo Biocompatibility of Graphene Oxide through Surface Modification: Poly(Acrylic Acid)-Functionalization is Superior to PEGylation. ACS Nano. 2016; 10(3):3267-81. DOI: 10.1021/acsnano.6b00539. View

15.

Sasidharan A, Panchakarla L, Sadanandan A, Ashokan A, Chandran P, Girish C . Hemocompatibility and macrophage response of pristine and functionalized graphene. Small. 2012; 8(8):1251-63. DOI: 10.1002/smll.201102393. View

16.

Sanchez V, Jachak A, Hurt R, Kane A . Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem Res Toxicol. 2011; 25(1):15-34. PMC: 3259226. DOI: 10.1021/tx200339h. View

17.

Wang X . The expanding role of mitochondria in apoptosis. Genes Dev. 2001; 15(22):2922-33. View

18.

Gurunathan S, Jeong J, Han J, Zhang X, Park J, Kim J . Multidimensional effects of biologically synthesized silver nanoparticles in Helicobacter pylori, Helicobacter felis, and human lung (L132) and lung carcinoma A549 cells. Nanoscale Res Lett. 2015; 10:35. PMC: 4384991. DOI: 10.1186/s11671-015-0747-0. View

19.

Gurunathan S, Han J, Kim E, Park J, Kim J . Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule. Int J Nanomedicine. 2015; 10:2951-69. PMC: 4404963. DOI: 10.2147/IJN.S79879. View

20.

Ryoo S, Kim Y, Kim M, Min D . Behaviors of NIH-3T3 fibroblasts on graphene/carbon nanotubes: proliferation, focal adhesion, and gene transfection studies. ACS Nano. 2010; 4(11):6587-98. DOI: 10.1021/nn1018279. View